Covidien launches a voluntary recall of the entire production lot of the Duet TRS endoscopic staple loading units and warns docs not to use the devices in thoracic surgeries.

Covidien plc (NYSE:COV) launched a voluntary recall of the entire production lot of its Duet TRS single-use heads for thoracic surgery after the company received reports of 13 serious injuries and 3 deaths following use.
"The company has concluded that Duet TRS has the potential to injure adjacent anatomical structures within the thorax, which may result in life-threatening, post-operative complications," according to a press release.
Covidien champions positive results for the Barrett's esophagus ablation device it acquired along...
Illinois healthcare giant Abbott lands European regulatory approval for the Xience Xpedition 48,...
ALung Technologies says it's going for a Chinese regulatory nod for its Hemolung respiratory assist...
An attorney for a plaintiff suing robot-assisted surgical systems maker Intuitive Surgical says the...
The American Stroke Assn. and partners release the Spot a Stroke F.A.S.T. smartphone app to help...